4//SEC Filing
Doyle Janeen Noel 4
Accession 0002069239-26-000002
CIK 0001817713other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 9:00 PM ET
Size
7.3 KB
Accession
0002069239-26-000002
Insider Transaction Report
Form 4
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
Transactions
- Award
Common Stock
2026-01-02+36,000→ 80,000 total - Award
Stock option (right to buy)
2026-01-02+126,000→ 126,000 totalExercise: $13.65Exp: 2036-01-01→ Common Stock (126,000 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
- [F2]25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0002069239
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 9:00 PM ET
- Size
- 7.3 KB